Αποτελέσματα Αναζήτησης
6 Μαρ 2024 · New Once-Daily HIV Oral Alternative Advances A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 study of people with HIV who are virologically suppressed, presented the Conference on Retrovirus and Opportunistic Infections (CROI) in ...
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
17 Απρ 2024 · New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
18 Νοε 2021 · Thousands of people with HIV will now be offered a new long-acting injection to manage their condition if they would prefer to stop taking daily pills. Charities have welcomed the approval of the...
23 Δεκ 2021 · The Food and Drug Administration has approved the first injectable medication for HIV prevention. Health advocates say it could be a game changer in protecting people against AIDS
14 Ιουλ 2020 · “This approval marks a new class of antiretroviral medications that may benefit patients who have run out of HIV treatment options,” said Jeff Murray, M.D., deputy director of the Division of Antivirals in the FDA’s Center for Drug Evaluation and Research.
31 Ιουλ 2024 · This table lists FDA approved HIV medicines recommended in HHS HIV/AIDS Guidelines. Click on a drug name to see information from the Clinicalinfo drug database.
